Discover and read the best of Twitter Threads about #survivorship

Most recents (4)

Wonderful presentation by Dr @TSNolanPhD in the @OSUCCC_James Spielman series this morning on her research on #survivorship needs of Black younger women #survonc #supponc #bcsm @osunursing 1/
Read 6 tweets
South Australian High school students - unsure about your career in science?

This Monday, you'll have a chance to learn about where a career in science can take you!

A thread 👇

Register here: trybooking.com/BLGZH

Event page: facebook.com/events/3060628… Image
Meet Michelle Forgione @ForgioneAu.

Michelle is a #PhDcandidate at @sahmriAU, researching acute lymphoblastic #leukaemia. She has special interests in #cancer epigenetics and #pharmacogenomics. Image
Meet Dr Hannah Wardill is a #NHMRC CJ Martin Biomedical Research Fellow.

@hannahrwardill is developing personalised #supponc solutions for the #ConsequencesOfTreatment to ensure people with cancer don’t just survive, but they survive well! #CuredatWhatCost #survivorship Image
Read 11 tweets
1/13 #FOAMed #MedTwitter

Everything I've learnt about living and beyond #cancer research (#lwbc) over the last 3⃣ years in this 8⃣ minute video! #survonc #survivorship in primary care covering:

➡️ Research
➡️ Policy
➡️ Practice
➡️ Future Directions

🔗:
2/13

I wrote a couple of articles in:

@BJGPjournal 🔗: bjgp.org/content/70/694…

@CHematology 🔗: sciencedirect.com/science/articl…

👆🏽 But summarised the content in the video above 👆🏽

@Nicholas_Ralph
3/13

🤔 What is "living with and beyond cancer" or #cancer #survivorship#survonc #lwbc

The definition depends on who you talk to! Is it at diagnosis, at the start of treatment or after treatment has finished?

🔗: bjgp.org/content/61/592…

🔗: cancer.net/survivorship/w…
Read 14 tweets
Hey #tipsfornewdocs #medtwitter folks! I wanted to review side effects of immune checkpoint inhibitors (ICIs) for a non-#oncology audience. Immune-related adverse events (irAEs) present across all medicine specialties so we are all in this together. 1/x
The most common ICIs are against PD-1 (e.g. nivolumab, pembrolizumab) and PD-L1 (e.g. atezolizumab, durvalumab). I use a blanket term “PD-1” throughout. Anti-CTLA-4 (ipilimumab) is a distant second; often in combo or directly after PD-1 in #melanoma #lung #kidney cancers. 2/x
They have led to pharma riches and Nobel Prizes and lots of TV commercials because they work really well for some patients. People with advanced #melanoma, #lcsm etc who used to live ~1 year now can hope to live for several years or more. 3/x
Read 17 tweets

Related hashtags

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3.00/month or $30.00/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!